WAVE Life Sciences Ltd (FRA:1U5)
€ 12.8 -0.1 (-0.78%) Market Cap: 1.89 Bil Enterprise Value: 1.62 Bil PE Ratio: 0 PB Ratio: 13.52 GF Score: 41/100

WAVE Life Sciences Ltd Investor Event Transcript

Sep 28, 2022 / 02:00PM GMT
Release Date Price: €4.04 (+7.04%)
Operator

Hello, and welcome to the Wave Life Sciences 2022 Analyst and Investor Webcast titled Towards the Clinic: Spotlight on RNA Editing for AATD. (Operator Instructions). Please note that today's broadcast is being recorded and webcast. Following the prepared remarks, management will take questions via the phone line. (Operator Instructions) It is now my pleasure to turn today's program over to Kate Rausch.

Kate Rausch
Wave Life Sciences Ltd. - Head of IR

Thank you, operator. Good morning, and thank you for joining us for this event.

The slides that accompany today's presentation will be available on the Investors section of our website at www.wavelifesciences.com. Before we begin, I would like to remind you that management may be making forward-looking statements during today's presentation. These statements are subject to a number of risks and uncertainties that could cause our actual results to differ materially from those described in these forward-looking statements. The factors

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot